Sana Biotechnology, Inc.
SANA
$1.76
-$0.01-0.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 152.50M | 199.01M | 251.64M | 311.08M | 205.20M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.48M | 7.31M | 7.98M | 6.35M | 4.49M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.83M | 3.83M | 3.83M | 3.83M | 3.83M |
| Total Current Assets | 160.81M | 210.15M | 263.45M | 321.26M | 213.52M |
|
|
|||||
| Total Current Assets | 160.81M | 210.15M | 263.45M | 321.26M | 213.52M |
| Net Property, Plant & Equipment | 135.27M | 143.87M | 149.06M | 153.21M | 145.59M |
| Long-term Investments | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M |
| Goodwill | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M |
| Total Other Intangibles | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.12M | 5.56M | 6.33M | 7.08M | 6.37M |
| Total Assets | 501.02M | 559.39M | 618.67M | 681.38M | 565.30M |
|
|
|||||
| Total Accounts Payable | 5.21M | 2.99M | 3.82M | 6.10M | 4.11M |
| Total Accrued Expenses | 27.39M | 33.21M | 33.88M | 28.59M | 37.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.83M | 10.60M | 10.00M | 13.17M | 13.20M |
| Total Finance Division Other Current Liabilities | -- | 199.00K | 3.00M | 5.05M | 9.20M |
| Total Other Current Liabilities | -- | 199.00K | 3.00M | 5.05M | 9.20M |
| Total Current Liabilities | 45.43M | 47.00M | 50.69M | 52.90M | 64.49M |
|
|
|||||
| Total Current Liabilities | 45.43M | 47.00M | 50.69M | 52.90M | 64.49M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 89.06M | 85.48M | 88.56M | 92.92M | 90.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 116.02M | 134.43M | 139.77M | 160.41M | 122.41M |
| Total Liabilities | 250.52M | 266.91M | 279.02M | 306.24M | 277.79M |
|
|
|||||
| Common Stock & APIC | 1.86B | 1.85B | 1.84B | 1.82B | 1.63B |
| Retained Earnings | -1.60B | -1.56B | -1.50B | -1.45B | -1.34B |
| Treasury Stock & Other | 14.00K | 54.00K | -19.00K | -15.00K | -60.00K |
| Total Common Equity | 250.50M | 292.48M | 339.65M | 375.14M | 287.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 250.50M | 292.48M | 339.65M | 375.14M | 287.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 250.50M | 292.48M | 339.65M | 375.14M | 287.51M |
|
|
|||||